Drugs / FTD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02031055 | Feb → Nov 2014 | cancer | Taiho Oncology, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FTD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02031055 ↗ |
| Route | Oral | “administered as an oral solution” NCT02031055 ↗ |